TRT therapy is designed to restore these levels, alleviating symptoms and improving overall well-being
This growth is driven by the increasing prevalence of type 2 diabetes and obesity, with GLP-1 receptor agonists offering effective treatment options that help manage blood sugar levels, promote weight loss, and reduce cardiovascular risks
information on active UK trials can be found via the NIHR Be Part of Research platform (bepartofresearch.nihr.ac.uk), the ISRCTN registry (isrctn.com), or the international ClinicalTrials.gov registry
Instead of making identical copies of the weight loss drugs, Empower and other compounders combine a GLP-1, either semaglutide or tirzepatide, with vitamin B12, change the dosage strength, or offer different delivery methods